Hyperferritinemia Wins Again: Defining Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus

REFERENCES

1. 1.↵
   1. Henderson LA,
   2. Cron RQ

   . Macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in childhood inflammatory disorders: diagnosis and management. Paediatr Drugs 2020;22:29-44.

   OpenUrlPubMed
2. 2.↵
   1. Ravelli A,
   2. Minoia F,
   3. Davi S,
   4. Horne A,
   5. Bovis F,
   6. Pistorio A, et al; Paediatric Rheumatology International Trials Organisation; Childhood Arthritis and Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Histiocyte Society

   . 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation collaborative initiative. Arthritis Rheumatol 2016;68:566-76.

   OpenUrl
3. 3.↵
   1. Minoia F,
   2. Bovis F,
   3. Davi S,
   4. Horne A,
   5. Fischbach M,
   6. Frosch M, et al; Pediatric Rheumatology International Trials Organization, the Childhood Arthritis & Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group and the Histiocyte Society

   . Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis 2019;78:1357-62.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Parodi A,
   2. Davi S,
   3. Pringe AB,
   4. Pistorio A,
   5. Ruperto N,
   6. Magni-Manzoni S, et al; Lupus Working Group of the Paediatric Rheumatology European Society

   . Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 2009;60:3388-99.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Gerstein M,
   2. Borgia RE,
   3. Dominguez D,
   4. Feldman BM,
   5. Liao F,
   6. Levy D, et al.

   Predicting macrophage activation syndrome (MAS) in childhood-onset systemic lupus erythematosus (cSLE) patients at diagnosis. J Rheumatol 2021;48:1450-7.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Henter JI,
   2. Horne A,
   3. Arico M,
   4. Egeler RM,
   5. Filipovich AH,
   6. Imashuku S, et al.

   HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Bleesing J,
   2. Prada A,
   3. Siegel DM,
   4. Villanueva J,
   5. Olson J,
   6. Ilowite NT, et al.

   The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007;56:965-71.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Behrens EM,
   2. Beukelman T,
   3. Paessler M,
   4. Cron RQ

   . Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 2007;34:1133-8.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Zulian F,
   2. Piccinini P,
   3. Martini G,
   4. Jorini M,
   5. de Benedictis FM

   . Macrophage activation syndrome as trigger event for systemic lupus erythematosus in children. J Paediatr Child Health 2009;45:621-2.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Vilaiyuk S,
    2. Sirachainan N,
    3. Wanitkun S,
    4. Pirojsakul K,
    5. Vaewpanich J

    . Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review. Clin Rheumatol 2013;32:899-904.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Pringe A,
    2. Trail L,
    3. Ruperto N,
    4. Buoncompagni A,
    5. Loy A,
    6. Breda L, et al.

    Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication? Lupus 2007;16:587-92.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Bennett TD,
    2. Fluchel M,
    3. Hersh AO,
    4. Hayward KN,
    5. Hersh AL,
    6. Brogan TV, et al.

    Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis. Arthritis Rheum 2012;64:4135-42.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Borgia RE,
    2. Gerstein M,
    3. Levy DM,
    4. Silverman ED,
    5. Hiraki LT

    . Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus. Arthritis Rheumatol 2018;70:616-24.

    OpenUrl
14. 14.↵
    1. Aytac S,
    2. Batu ED,
    3. Unal S,
    4. Bilginer Y,
    5. Cetin M,
    6. Tuncer M, et al.

    Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus. Rheumatol Int 2016;36:1421-9.

    OpenUrl
15. 15.↵
    1. Halyabar O,
    2. Chang MH,
    3. Schoettler ML,
    4. Schwartz MA,
    5. Baris EH,
    6. Benson LA, et al.

    Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome. Pediatr Rheumatol Online J 2019;17:7.

    OpenUrl
16. 16.↵
    1. Hoyt K,
    2. Halyabar O,
    3. Han J,
    4. Case SM,
    5. Chang MH,
    6. Platt CD, et al.

    Outcomes of an evidence based guideline for the treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome [abstract]. Arthritis Rheumatol 2020;72.
17. 17.↵
    1. Eloseily EMA,
    2. Minoia F,
    3. Crayne CB,
    4. Beukelman T,
    5. Ravelli A,
    6. Cron RQ

    . Ferritin to erythrocyte sedimentation rate ratio: simple measure to identify macrophage activation syndrome in systemic juvenile idiopathic arthritis. ACR Open Rheumatol 2019;1:345-9.

    OpenUrl